Publikationen, an denen er mitarbeitet José María Rojas Cabañeros (46)

2023

  1. PKD phosphorylation and COP9/Signalosome modulate intracellular Spry2 protein stability

    Oncogenesis, Vol. 12, Núm. 1

2018

  1. Erratum: The P34g mutation reduces the transforming activity of K-Ras and N-Ras in NIH 3T3 cells but not of H-Ras (Journal of Biological Chemistry (2004) 279:32 (33480-91) DOI: 10.1074/jbc.M204423200)

    Journal of Biological Chemistry

  2. Erratum: hSos1 contains a new amino-terminal regulatory motif with specific binding affinity for its pleckstrin homology domain(Journal of Biological Chemistry (2002) 277:46 (44171-9) DOI: 10.1074/jbc.M204423200)

    Journal of Biological Chemistry

2016

  1. SPROUTY-2 represses the epithelial phenotype of colon carcinoma cells via upregulation of ZEB1 mediated by ETS1 and miR-200/miR-150

    Oncogene, Vol. 35, Núm. 23, pp. 2991-3003

2014

  1. Regulation of CBP and Tip60 coordinates histone acetylation at local and global levels during Ras-induced transformation

    Carcinogenesis, Vol. 35, Núm. 10, pp. 2194-2202

  2. Shoc2/Sur8 protein regulates neurite outgrowth

    PLoS ONE, Vol. 9, Núm. 12

2012

  1. Intersectin 1 enhances Cbl ubiquitylation of epidermal growth factor receptor through regulation of sprouty2-Cbl interaction

    Molecular and Cellular Biology, Vol. 32, Núm. 4, pp. 817-825

2011

  1. Sprouty2 and spred1-2 proteins inhibit the activation of the ERK pathway elicited by cyclopentenone prostanoids

    PLoS ONE, Vol. 6, Núm. 2

  2. The C-terminus of H-ras as a target for the covalent binding of reactive compounds modulating Ras-dependent pathways

    PLoS ONE, Vol. 6, Núm. 1

2010

  1. SPROUTY-2 and E-cadherin regulate reciprocally and dictate colon cancer cell tumourigenicity

    Oncogene, Vol. 29, Núm. 34, pp. 4800-4813

2009

  1. Cell density-dependent inhibition of epidermal growth factor receptor signaling by p38α mitogen-activated protein kinase via sprouty2 downregulation

    Molecular and Cellular Biology, Vol. 29, Núm. 12, pp. 3332-3343

  2. SJ23B, a jatrophane diterpene activates classical PKCs and displays strong activity against HIV in vitro

    Biochemical Pharmacology, Vol. 77, Núm. 6, pp. 965-978

2008

  1. E1a gene expression blocks the ERK1/2 signaling pathway by promoting nuclear localization and MKP up-regulation: Implication in v-H-Ras-induced senescence

    Journal of Biological Chemistry, Vol. 283, Núm. 19, pp. 13450-13458

  2. Endothelial nitric oxide synthase regulates N-Ras activation on the Golgi complex of antigen-stimulated T cells

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 105, Núm. 30, pp. 10507-10512

  3. Nuclear exclusion of forkhead box O and Elk1 and activation of nuclear factor-κB are required for C2C12-RasV12C40 myoblast differentiation

    Endocrinology, Vol. 149, Núm. 2, pp. 793-801

  4. Plitidepsin has a dual effect inhibiting cell cycle and inducing apoptosis via Rac1/c-Jun NH2-terminal kinase activation in human melanoma cells

    Journal of Pharmacology and Experimental Therapeutics, Vol. 324, Núm. 3, pp. 1093-1101

2007

  1. Modification and activation of Ras proteins by electrophilic prostanoids with different structure are site-selective

    Biochemistry, Vol. 46, Núm. 22, pp. 6607-6616

  2. Sprouty2 binds Grb2 at two different proline-rich regions, and the mechanism of ERK inhibition is independent of this interaction

    Cellular Signalling, Vol. 19, Núm. 11, pp. 2277-2285

2006

  1. Aplidin® induces JNK-dependent apoptosis in human breast cancer cells via alteration of glutathione homeostasis, Rac1 GTPase activation, and MKP-1 phosphatase downregulation

    Cell Death and Differentiation, Vol. 13, Núm. 11, pp. 1968-1981

  2. Grb2 is a negative modulator of the intrinsic Ras-GEF activity of hSos1

    Molecular Biology of the Cell, Vol. 17, Núm. 8, pp. 3591-3597